GlassScriptPhysician profile
Ajay Sheshadri
NPI 1801096854
$25,879.31
in general payments reported to CMS, 2019-2025
6 companies · $2,771 in 2025
The $2,771 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,819 · 2023: $5,250 · 2024: $16K · 2025: $2,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Honoraria: $3,750 · Travel and Lodging: $1,351 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,544.00 |
| Honoraria | $3,750.00 |
| Travel and Lodging | $1,351.48 |
| Food and Beverage | $415.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12,185.60 | 2024-2025 | |
| Pfizer INC. | $6,375.00 | 2024-2025 | |
| Adc Therapeutics America, INC. | $5,250.00 | 2023 | |
| Nabriva Therapeutics, Plc | $1,781.87 | 2022 | |
| Canon Medical Systems Corporation | $250.00 | 2024 | Vitrea Advanced Visualization, Aze Virtual Place |
| Genentech, INC. | $36.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Sheshadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.